The 4 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +50.50% increase from the last price of 5.98.
The current consensus among 4 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.33
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.